A high-quality, open access journal edited by experts in diabetes and endocrinology. Published by BMJ in partnership with the American Diabetes Association.
We’re making an impact together.
Take a look at our latest journal metrics 📊 Impact Factor and top-cited content. https://t.co/6aLzI7TG7w
Behind every published finding is a shared purpose: advancing medical knowledge to improve patient health. #JournalMetrics#BMJGroupImpact
Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry
Learn more 👉 https://t.co/ANwSeCe7Mt
Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes (T2D)
Learn more:
👉 https://t.co/evTcZ73NjP
Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin
Learn more 👇
https://t.co/0eylbMpsp3
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
Follow this link to review the latest guidance from the American Diabetes Association (ADA) on pharmacologic management of obesity in adults
👉 https://t.co/maRj1EKkMt
Effects of benfotiamine treatment over 12 months on morphometric, neurophysiological and clinical measures in type 2 diabetes patients with symptomatic polyneuropathy: a randomized, placebo-controlled, double-blind clinical trial (BOND study)
👀 Read the full paper here: https://t.co/2sO3djMVLR
Zero Dollar Drug Copay program improves antidiabetic medication adherence and medication use patterns among Blue Cross and Blue Shield of Louisiana members with diabetes in Louisiana
Learn more 👇
https://t.co/1qUrpzaK7b
Associations of body weight and COVID-19 with autoimmunity in pediatric new-onset type 1 diabetes: results from the prospective DPV registry
Learn more 👉 https://t.co/ANwSeCe7Mt
Metal mixture inflammatory index and diabetes risk in US adults: a cross-sectional analysis of NHANES 1999-2020 and development of a LASSO-based prediction model
Learn more 👉 https://t.co/Jq3FjzhYeA
Trends in delaying and forgoing medical care due to cost and the association with insurance status among US adults with diabetes, 2009-2023
👀 https://t.co/LD480AoxOE
HOT OFF THE PRESS!
Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity
Follow this link to review the brand new recommendations from the American Diabetes Association (ADA) on pharmacologic management of obesity in adults
👉
Identifying interhospital variation in hyperosmolar hyperglycemic syndrome (HHS) care: development and outcomes of the DEKODE HHS model
👇 Learn more
https://t.co/s60PYirKkE
Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists in heart failure patients with type 2 diabetes (T2D)
Learn more 👉 https://t.co/TtEZIXQzoI